TrialEuropean journal of clinical pharmacology2012

CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected Zimbabweans.

Milimo Maimbo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.